Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation

Oncogene

Volumn 26, Issue 37, 2007, Pages 5341-5357

  Nagy, Z ^a   Tora, L ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

ATAC; Cofactors; Global histone acetylation; SAGA complexes; STAGA; TFTC

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE GCN5; HISTONE ACETYLTRANSFERASE PCAF; MULTIPROTEIN COMPLEX; RNA POLYMERASE II; SINGLE STRANDED DNA; TATA BINDING PROTEIN; TRANSCRIPTION FACTOR;

ACETYLATION; CANCER; CARCINOGENESIS; CHROMATIN STRUCTURE; DEREGULATION; DNA REPAIR; DROSOPHILA; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; IN VIVO STUDY; METAZOON; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW;

ACETYLATION; ANIMALS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CHROMATIN; DNA REPAIR; GENE EXPRESSION REGULATION; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; MULTIENZYME COMPLEXES; PROTEIN CONFORMATION; PROTEIN SUBUNITS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EUKARYOTA; METAZOA;

EID: 34547864553     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210604     Document Type: Review

References (166)

1. Agalioti T, Lomvardas S, Parekh B, Yie J, Maniatis T, Thanos D. (2000). Ordered recruitment of chromatin modifying and general transcription factors to the IFN-beta promoter. Cell 103: 667-678.
2. Akhtar A, Becker PB. (2000). Activation of transcription through histone H4 acetylation by MOF, an acetyltransferase essential for dosage compensation in Drosophila. Mol Cell 5: 367-375.
3. Anafi M, Yang YF, Barlev NA, Govindan MV, Berger SL, Butt TR et al. (2000). GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Mol Endocrinol 14: 718-732.
4. Appella E, Anderson CW. (2001). Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268: 2764-2772.
5. Avvakumov N, Torchia J, Mymryk JS. (2003). Interaction of the HPV E7 proteins with the PCAF acetyltransferase. Oncogene 22: 3833-3841.
6. Baker SJ, Grant PA. (2007). The SAGA continues: expending the cellular role of a transcriptional coactivator complex. Oncogene 26: 5341-5357.
7. Bannister AJ, Miska EA. (2000). Regulation of gene expression by transcription factor acetylation. Cell Mol Life Sci 57: 1184-1192.
8. Barlev NA, Emelyanov AV, Castagnino P, Zegerman P, Bannister AJ, Sepulveda MA et al. (2003). A novel human Ada2 homologue functions with Gcn5 or Brg1 to coactivate transcription. Mol Cell Biol 23: 6944-6957.
9. Barrera LO, Ren B. (2006). The transcriptional regulatory code of eukaryotic cells - insights from genome-wide analysis of chromatin organization and transcription factor binding. Curr Opin Cell Biol 18: 291-298.
10. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL et al. (2006). The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res 66: 5330-5337.
11. Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y et al. (1998). Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J Biol Chem 273: 24898-24905.
12. Berger SL, Pina B, Silverman N, Marcus GA, Agapite J, Regier JL et al. (1992). Genetic isolation of ADA2: a potential transcriptional adaptor required for function of certain acidic activation domains. Cell 70: 251-265.
13. Bode AM, Dong Z. (2004). Post-translational modification of p53 in tumorigenesis. Nat Rev Cancer 4: 793-805.
14. Bootsma D, Hoeijmakers JH. (1993). DNA repair. Engagement with transcription. Nature 363: 114-115.
15. Boulton SJ. (2006a). BRCA1-mediated ubiquitylation. Cell Cycle 5: 1481-1486.
16. Boulton SJ. (2006b). Cellular functions of the BRCA tumour-suppressor proteins. Biochem Soc Trans 34: 633-645.
17. Brand M, Leurent C, Mallouh V, Tora L, Schultz P. (1999a). Three-dimensional structures of the TAFII-containing complexes TFIID and TFTC. Science 286: 2151-2153.
18. Brand M, Moggs JG, Oulad-Abdelghani M, Lejeune F, Dilworth FJ, Stevenin J et al. (2001). UV-damaged DNA-binding protein in the TFTC complex links DNA damage recognition to nucleosome acetylation. EMBO J 20: 3187-3196.
19. Brand M, Yamamoto K, Staub A, Tora L. (1999b). Identification of TATA-binding protein-free TAFII-containing complex subunits suggests a role in nucleosome acetylation and signal transduction. J Biol Chem 274: 18285-18289.
20. Brown CE, Lechner I, Howe I, Workman JL. (2000). The many HATs of transcription coactivators. Trends Biochem Sci 25: 15-19.
21. Brownell JE, Allis CD. (1996). Special HATs for special occasions: linking histone acetylation to chromatin assembly and gene activation. Curr Opin Genet Dev 6: 176-184.
22. Brownell JE, Zhou J, Ranalli T, Kobayashi R, Edmondson DG, Roth SY et al. (1996). Tetrahymena histone acetyltransferase A: a homolog to yeast Gcn5p linking histone acetylation to gene activation. Cell 84: 843-851.
23. Candau R, Scolnick DM, Darpino P, Ying CY, Halazonetis TD, Berger SL. (1997). Two tandem and independent subactivation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene 15: 807-816.
24. Carey M, Li B, Workman JL. (2006). RSC exploits histone acetylation to abrogate the nucleosomal block to RNA polymerase II elongation. Mol Cell 24: 481-487.
25. Caron C, Boyault C, Khochbin S. (2005). Regulatory cross-talk between lysine acetylation and ubiquitination: role in the control of protein stability. Bioessays 27: 408-415.
26. Carre C, Szymczak D, Pidoux J, Antoniewski C. (2005). The histone H3 acetylase dGcn5 is a key player in Drosophila melanogaster metamorphosis. Mol Cell Biol 25: 8228-8238.
27. Carrozza MJ, Utley RT, Workman JL, Cote J. (2003). The diverse functions of histone acetyltransferase complexes. Trends Genet 19: 321-329.
28. Carruthers LM, Hansen JC. (2000). The core histone N terminal function independently of linker histones during chromatin condensation. J Biol Chem 275: 37285-37290.
29. Cavusoglu N, Brand M, Tora L, Van Dorsselaer A. (2003). Novel subunits of the TATA binding protein free TAFII-containing transcription complex identified by matrix-assisted laser desorption/ionization-time of flight mass spectrometry following one-dimensional gel electrophoresis. Proteomics 3: 217-223.
30. Chakravarti D, Ogryzko V, Kao HY, Nash A, Chen H, Nakatani Y et al. (1999). A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96: 393-403.
31. Cheung WL, Briggs SD, Allis CD. (2000). Acetylation and chromosomal functions. Curr Opin Cell Biol 12: 326-333.
32. Ciurciu A, Komonyi O, Pankotai T, Boros IM. (2006). The Drosophila histone acetyltransferase Gcn5 and transcriptional adaptor Ada2a are involved in nucleosomal histone H4 acetylation. Mol Cell Biol 26: 9413-9423.
33. Clements A, Rojas JR, Trievel RC, Wang L, Berger SL, Marmorstein R. (1999). Crystal structure of the histone acetyltransferase domain of the human PCAFtranscriptional regulator bound to coenzyme A. EMBO J 18: 3521-3532.
34. Das BK, Xia L, Palandjian L, Gozani O, Chyung Y, Reed R. (1999). Characterization of a protein complex containing spliceosomal proteins SAPs 49, 130, 145, and 155. Mol Cell Biol 19: 6796-6802.
35. de la Cruz X, Lois S, Sanchez-Molina S, Martinez-Balbas MA. (2005). Do protein motifs read the histone code? Bioessays 27: 164-175.
36. Demeny MA, Soutoglou E, Nagy Z, Scheer E, Janoshazi A, Richardot M et al. (2007). Identification of a small TAF complex and its role in the assembly of TAF-containing complexes. PLoS ONE 2: e316.
37. Dhalluin C, Carlson JE, Zeng L, He C, Aggarwal AK, Zhou MM. (1999). Structure and ligand of a histone acetyltransferase bromodomain. Nature 399: 491-496.
38. Di Stefano V, Soddu S, Sacchi A, D'Orazi G. (2005). HIPK2 contributes to PCAF-mediated p53 acetylation and selective transactivation of p21Waf1 after nonapoptotic DNA damage. Oncogene 24: 5431-5442.
39. Dyson N, Howley PM, Munger K, Harlow E. (1989). The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 243: 934-937.
40. Eberharter A, Becker PB. (2002). Histone acetylation: a switch between repressive and permissive chromatin: second in review series on chromatin dynamics. EMBO Rep 3: 224-229.
41. Eberharter A, Sterner DE, Schieltz D, Hassan A, Yates JR, Berger SL et al. (1999). The ADA complex is a distinct histone acetyltransferase complex in saccharomyces cerevisiae (in process citation). Mol Cell Biol 19: 6621-6631.
42. Fan S, Wang J, Yuan R, Ma Y, Meng Q, Erdos MR et al. (1999). BRCA1 inhibition of estrogen receptor signaling in transfected cells. Science 284: 1354-1356.
43. Feng L, Lin T, Uranishi H, Gu W, Xu Y. (2005). Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity. Mol Cell Biol 25: 5389-5395.
44. Fischle W, Wang Y, Allis CD. (2003). Histone and chromatin cross-talk. Curr Opin Cell Biol 15: 172-183.
45. Flinn EM, Wallberg AE, Hermann S, Grant PA, Workman JL, Wright AP. (2002). Recruitment of Gcn5-containing complexes during c-Myc-dependent gene activation. Structure and function aspects. J Biol Chem 277: 23399-23406.
46. Forsberg EC, Lam LT, Yang XJ, Nakatani Y, Bresnick EH. (1997). Human histone acetyltransferase GCN5 exists in a stable macromolecular complex lacking the adapter ADA2. Biochemistry 36: 15918-15924.
47. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM et al. (2003). MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4: 575-580.
48. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B. (2001). Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 15: 2069-2082.
49. Fuks F, Milner J, Kouzarides T. (1998). BRCA2 associates with acetyltransferase activity when bound to P/CAF. Oncogene 17: 2531-2534.
50. Georgieva S, Kirschner DB, Jagla T, Nabirochkina E, Hanke S, Schenkel H et al. (2000). Two novel Drosophila TAF(II)s have homology with human TAF(II)30 and are differentially regulated during development. Mol Cell Biol 20: 1639-1648.
51. Georgieva S, Nabirochkina E, Dilworth FJ, Eickhoff H, Becker P, Tora L et al. (2001). The novel transcription factor e(y)2 interacts with TAF(II)40 and potentiates transcription activation on chromatin templates. Mol Cell Biol 21: 5223-5231.
52. Glozak MA, Sengupta N, Zhang X, Seto E. (2005). Acetylation and deacetylation of non-histone proteins. Gene 363: 15-23.
53. Govind CK, Zhang F, Qiu H, Hofmeyer K, Hinnebusch AG. (2007). Gcn5 promotes acetylation, eviction, and methylation of nucleosomes in transcribed coding regions. Mol Cell 25: 31-42.
54. Grant PA, Duggan L, Cote J, Roberts SM, Brownell JE, Candau R et al. (1997). Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt/Ada) complex. Genes Dev 11: 1640-1650.
55. Grant PA, Eberharter A, John S, Cook RG, Turner BM, Workman JL. (1999). Expanded lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem 274: 5895-5900.
56. Grant PA, Schieltz D, Pray-Grant MG, Steger DJ, Reese JC, Yates JR et al. (1998a). A subset of TAF(II)s are integral components of the SAGA complex required for nucleosome acetylation and transcriptional stimulation. Cell 94: 45-53.
57. Grant PA, Sterner DE, Duggan LJ, Workman JL, Berger SL. (1998b). The SAGA unfolds: convergence of transcription regulators in chromatin-modifying complexes. Trends Cell Biol 8: 193-197.
58. Gu W, Roeder RG. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606.
59. Guelman S, Suganuma T, Florens L, Swanson SK, Kiesecker CL, Kusch T et al. (2006a). Host cell factor and an uncharacterized SANT domain protein are stable components of ATAC, a novel dAda2A/dGcn5-containing histone acetyltransferase complex in Drosophila. Mol Cell Biol 26: 871-882.
60. Guelman S, Suganuma T, Florens L, Weake V, Swanson SK, Washburn MP et al. (2006b). The essential gene wda encodes a WD40 repeat subunit of Drosophila SAGA required for histone H3 acetylation. Mol Cell Biol 26: 7178-7189.
61. Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY et al. (1999). Regulation of histone acetyltransferases p300 and PCAFby the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96: 405-413.
62. Harrod R, Kuo YL, Tang Y, Yao Y, Vassilev A, Nakatani Y et al. (2000). p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex. J Biol Chem 275: 11852-11857.
63. Harrod R, Nacsa J, Van Lint C, Hansen J, Karpova T, McNally J et al. (2003). Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription. J Biol Chem 278: 12310-12318.
64. Hassan AH, Awad S, Al-Natour Z, Othman S, Mustafa F, Rizvi TA. (2007). Selective recognition of acetylated histones by bromodomains in transcriptional co-activators. Biochem J 402: 125-133.
65. Hassan AH, Neely KE, Vignali M, Reese JC, Workman JL. (2001a). Promoter targeting of chromatin-modifying complexes. Front Biosci 6: D1054-D1064.
66. Hassan AH, Neely KE, Workman JL. (2001b). Histone acetyltransferase complexes stabilize swi/snf binding to promoter nucleosomes. Cell 104: 817-827.
67. Hassan AH, Prochasson P, Neely KE, Galasinski SC, Chandy M, Carrozza MJ et al. (2002). Function and selectivity of bromodomains in anchoring chromatin-modifying complexes to promoter nucleosomes. Cell 111: 369-379.
68. Helmlinger D, Hardy S, Abou-Sleymane G, Eberlin A, Bowman AB, Gansmuller A et al. (2006a). Glutamine-expanded ataxin-7 alters TFTC/STAGA recruitment and chromatin structure leading to photoreceptor dysfunction. PLoS Biol 4: e67.
69. Helmlinger D, Hardy S, Sasorith S, Klein F, Robert F, Weber C et al. (2004). Ataxin-7 is a subunit of GCN5 histone acetyltransferase- containing complexes. Hum Mol Genet 13: 1257-1265.
70. Helmlinger D, Tora L, Devys D. (2006b). Transcriptional alterations and chromatin remodeling in polyglutamine diseases. Trends Genet 22: 562-570.
71. Hudson BP, Martinez-Yamout MA, Dyson HJ, Wright PE. (2000). Solution structure and acetyl-lysine binding activity of the GCN5 bromodomain. J Mol Biol 304: 355-370.
72. Imoberdorf RM, Topalidou I, Strubin M. (2006). A role for gcn5-mediated global histone acetylation in transcriptional regulation. Mol Cell Biol 26: 1610-1616.
73. Jia L, Shen HC, Wantroba M, Khalid O, Liang G, Wang Q et al. (2006). Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells. Mol Cell Biol 26: 7331-7341.
74. Jiang H, Lu H, Schiltz RL, Pise-Masison CA, Ogryzko VV, Nakatani Y et al. (1999). PCAFinteracts with tax and stimulates tax transactivation in a histone acetyltransferase-independent manner. Mol Cell Biol 19: 8136-8145.
75. Johnson DG, Degregori J. (2006). Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med 6: 731-738.
76. Kahata K, Hayashi M, Asaka M, Hellman U, Kitagawa H, Yanagisawa J et al. (2004). Regulation of transforming growth factor-beta and bone morphogenetic protein signalling by transcriptional coactivator GCN5. Genes Cells 9: 143-151.
77. Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F et al. (1999). HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 18: 6106-6118.
78. Kikuchi H, Takami Y, Nakayama T. (2005). GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genes. Gene 347: 83-97.
79. Kim S, Ohkuni K, Couplan E, Jazwinski SM. (2004). The histone acetyltransferase GCN5 modulates the retrograde response and genome stability determining yeast longevity. Biogerontology 5: 305-316.
80. Kingston RE, Bunker CA, Imbalzano AN. (1996). Repression and activation by multiprotein complexes that alter chromatin structure. Genes Dev 10: 905-920.
81. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. (2006). Myc influences global chromatin structure. EMBO J 25: 2723-2734.
82. Kouzarides T. (2000). Acetylation: a regulatory modification to rival phosphorylation? EMBO J 19: 1176-1179.
83. Krajewski WA, Becker PB. (1998). Reconstitution of hyperacetylated, DNase I-sensitive chromatin characterized by high conformational flexibility of nucleosomal DNA. Proc Natl Acad Sci USA 95: 1540-1545.
84. Kuo MH, Allis CD. (1998). Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20: 615-626.
85. Kuo MH, Brownell JE, Sobel RE, Ranalli TA, Cook RG, Edmondson DG et al. (1996). Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature 383: 269-272.
86. Kurabe N, Katagiri K, Komiya Y, Ito R, Sugiyama A, Kawasaki Y et al. (2007). Deregulated expression of a novel component of TFTC/STAGA histone acetyltransferase complexes, rat SGF29, in hepatocellular carcinoma: possible implication for the oncogenic potential of c-Myc. Oncogene: 5 March 2007 [Epub ahead of print].
87. Kurdistani SK, Grunstein M. (2003). Histone acetylation and deacetylation in yeast. Nat Rev Mol Cell Biol 4: 276-284.
88. Kusch T, Guelman S, Abmayr SM, Workman JL. (2003). Two Drosophila Ada2 homologues function in different multiprotein complexes. Mol Cell Biol 23: 3305-3319.
89. Lancaster JM, Wooster R, Mangion J, Phelan CM, Cochran C, Gumbs C et al. (1996). BRCA2 mutations in primary breast and ovarian cancers. Nat Genet 13: 238-240.
90. Lang SE, McMahon SB, Cole MD, Hearing P. (2001). E2F transcriptional activation requires TRRAP and GCN5 cofactors. J Biol Chem 276: 32627-32634.
91. Lebedeva LA, Nabirochkina EN, Kurshakova MM, Robert F, Krasnov AN, Evgen'ev MB et al. (2005). Occupancy of the Drosophila hsp70 promoter by a subset of basal transcription factors diminishes upon transcriptional activation. Proc Natl Acad Sci USA 102: 18087-18092.
92. Lerin C, Rodgers JT, Kalume DE, Kim SH, Pandey A, Puigserver P. (2006). GCN5 acetyltransferase complex controls glucose metabolism through transcriptional repression of PGC-1alpha. Cell Metab 3: 429-438.
93. Lin HY, Chen CS, Lin SP, Weng JR, Chen CS. (2006). Targeting histone deacetylase in cancer therapy. Med Res Rev 26: 397-413.
94. Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O et al. (2007). Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 3: 331-338.
95. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD et al. (1999). p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19: 1202-1209.
96. Liu X, Tesfai J, Evrard YA, Dent SY, Martinez E. (2003). c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation. J Biol Chem 278: 20405-20412.
97. Marmorstein R. (2001). Structure and function of histone acetyltransferases. Cell Mol Life Sci 58: 693-703.
98. Martinez E, Kundu TK, Fu J, Roeder RG. (1998). A human SPT3-TAFII31-GCN5-L acetylase complex distinct from transcription factor IID. J Biol Chem 273: 23781-23785.
99. Martinez E, Palhan VB, Tjernberg A, Lymar ES, Gamper AM, Kundu TK et al. (2001). Human STAGA complex is a chromatin-acetylating transcription coactivator that interacts with pre-mRNA splicing and DNA damage-binding factors in vivo. Mol Cell Biol 21: 6782-6795.
100. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. (2000). Regulation of E2F1 activity by acetylation. EMBO J 19: 662-671.
101. Marzio G, Wagener C, Gutierrez MI, Cartwright P, Helin K, Giacca M. (2000). E2F family members are differentially regulated by reversible acetylation. J Biol Chem 275: 10887-10892.
102. Masumi A, Wang IM, Lefebvre B, Yang XJ, Nakatani Y, Ozato K. (1999). The histone acetylase PCAF is a phorbolester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol Cell Biol 19: 1810-1820.
103. McMahon SB, Van Buskirk HA, Dugan KA, Copeland TD, Cole MD. (1998). The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins. Cell 94: 363-374.
104. Milner J, Ponder B, Hughes-Davies L, Seltmann M, Kouzarides T. (1997). Transcriptional activation functions in BRCA2. Nature 386: 772-773.
105. Morris SA, Rao B, Garcia BA, Hake SB, Diaz RL, Shabanowitz J et al. (2006). Identification of histone H3 lysine 36 acetylation as a highly conserved histone modification. J Biol Chem 282: 7632-7640.
106. Muratoglu S, Georgieva S, Papai G, Scheer E, Enunlu I, Komonyi O et al. (2003). Two different Drosophila ADA2 homologues are present in distinct GCN5 histone acetyltransferase-containing complexes. Mol Cell Biol 23: 306-321.
107. Mutskov V, Gerber D, Angelov D, Ausio J, Workman J, Dimitrov S. (1998). Persistent interactions of core histone tails with nucleosomal DNA following acetylation and transcription factor binding. Mol Cell Biol 18: 6293-6304.
108. Narlikar GJ, Fan HY, Kingston RE. (2002). Cooperation between complexes that regulate chromatin structure and transcription. Cell 108: 475-487.
109. Nesbit CE, Tersak JM, Prochownik EV. (1999). MYC oncogenes and human neoplastic disease. Oncogene 18: 3004-3016.
110. Ogryzko VV, Kotani T, Zhang X, Schlitz RL, Howard T, Yang XJ et al. (1998). Histone-like TAFs within the PCAF histone acetylase complex. Cell 94: 35-44.
111. Oishi H, Kitagawa H, Wada O, Takezawa S, Tora L, Kouzu-Fujita M et al. (2006). An hGCN5/TRRAP histone acetyltransferase complex co-activates BRCA1 transactivation function through histone modification. J Biol Chem 281: 20-26.
112. Owen DJ, Ornaghi P, Yang JC, Lowe N, Evans PR, Ballario P et al. (2000). The structural basis for the recognition of acetylated histone H4 by the bromodomain of histone acetyltransferase gcn5p. EMBO J 19: 6141-6149.
113. Palhan VB, Chen S, Peng GH, Tjernberg A, Gamper AM, Fan Y et al. (2005). Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce retinal degeneration. Proc Natl Acad Sci USA 102: 8472-8477.
114. Pankotai T, Komonyi O, Bodai L, Ujfaludi Z, Muratoglu S, Ciurciu A et al. (2005). The homologous Drosophila transcriptional adaptors ADA2a and ADA2b are both required for normal development but have different functions. Mol Cell Biol 25: 8215-8227.
115. Paulson M, Press C, Smith E, Tanese N, Levy DE. (2002). IFN-stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol 4: 140-147.
116. Pina B, Berger S, Marcus GA, Silverman N, Agapite J, Guarente L. (1993). ADA3: a gene, identified by resistance to GAL4-VP16, with properties similar to and different from those of ADA2. Mol Cell Biol 13: 5981-5989.
117. Powell DW, Weaver CM, Jennings JL, McAfee KJ, He Y, Weil PA et al. (2004). Cluster analysis of mass spectrometry data reveals a novel component of SAGA. Mol Cell Biol 24: 7249-7259.
118. Prives C, Manley JL. (2001). Why is p53 acetylated? Cell 107: 815-818.
119. Qi D, Larsson J, Mannervik M. (2004). Drosophila Ada2b is required for viability and normal histone H3 acetylation. Mol Cell Biol 24: 8080-8089.
120. Roberts SM, Winston F. (1996). SPT20/ADA5 encodes a novel protein functionally related to the TATA-binding protein and important for transcription in Saccharomyces cerevisiae. Mol Cell Biol 16: 3206-3213.
121. Rockx DA, Mason R, van Hoffen A, Barton MC, Citterio E, Bregman DB et al. (2000). UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II (in process citation). Proc Natl Acad Sci USA 97: 10503-10508.
122. Rodriguez-Navarro S, Fischer T, Luo MJ, Antunez O, Brettschneider S, Lechner J et al. (2004). Sus1, a functional component of the SAGA histone acetylase complex and the nuclear pore-associated mRNA export machinery. Cell 116: 75-86.
123. Rojas JR, Trievel RC, Zhou J, Mo Y, Li X, Berger SL et al. (1999). Structure of tetrahymena GCN5 bound to coenzyme A and a histone H3 peptide. Nature 401: 93-98.
124. Roth SY, Denu JM, Allis CD. (2001). Histone acetyltransferases. Annu Rev Biochem 70: 81-120.
125. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841.
126. Sanders SL, Jennings J, Canutescu A, Link AJ, Weil PA. (2002). Proteomics of the eukaryotic transcription machinery: identification of proteins associated with components of yeast TFIID by multidimensional mass spectrometry. Mol Cell Biol 22: 4723-4738.
127. Schiltz RL, Mizzen CA, Vassilev A, Cook RG, Allis CD, Nakatani Y. (1999). Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem 274: 1189-1192.
128. Seligson DB, Horvath S, Shi T, Yu H, Tze S, Grunstein M et al. (2005). Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435: 1262-1266.
129. Sermwittayawong D, Tan S. (2006). SAGA binds TBP via its Spt8 subunit in competition with DNA: implications for TBP recruitment. EMBO J 25: 3791-3800.
130. Shamoo Y. (2003). Structural insights into BRCA2 function. Curr Opin Struct Biol 13: 206-211.
131. Sharan SK, Morimatsu M, Albrecht U, Lim DS, Regel E, Dinh C et al. (1997). Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature 386: 804-810.
132. Shilatifard A. (2006). Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression. Annu Rev Biochem 75: 243-269.
133. Shin S, Verma IM. (2003). BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription. Proc Natl Acad Sci USA 100: 7201-7206.
134. Shogren-Knaak M, Ishii H, Sun JM, Pazin MJ, Davie JR, Peterson CL. (2006). Histone H4-K16 acetylation controls chromatin structure and protein interactions. Science 311: 844-847.
135. Smith ER, Belote JM, Schiltz RL, Yang XJ, Moore PA, Berger SL et al. (1998). Cloning of Drosophila GCN5: conserved features among metazoan GCN5 family members. Nucleic Acids Res 26: 2948-2954.
136. Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ. (2006). HPV-mediated cervical carcinogenesis: concepts and clinical implications. J Pathol 208: 152-164.
137. Soutoglou E, Demeny MA, Scheer E, Fienga G, Sassone-Corsi P, Tora L. (2005). The nuclear import of TAF10 is regulated by one of its three histone fold domain-containing interaction partners. Mol Cell Biol 25: 4092-4104.
138. Spotts GD, Patel SV, Xiao Q, Hann SR. (1997). Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins. Mol Cell Biol 17: 1459-1468.
139. Sterner DE, Berger SL. (2000). Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev 64: 435-459.
140. Stockinger EJ, Mao Y, Regier MK, Triezenberg SJ, Thomashow MF. (2001). Transcriptional adaptor and histone acetyltransferase proteins in Arabidopsis and their interactions with CBF1, a transcriptional activator involved in cold-regulated gene expression. Nucleic Acids Res 29: 1524-1533.
141. 1. Mol Cell Biol 24: 4546-4556.
142. Timmers HT, Tora L. (2005). SAGA unveiled. Trends Biochem Sci 30: 7-10.
143. Tora L. (2002). A unified nomenclature for TATA box binding protein (TBP)-associated factors (TAFs) involved in RNA polymerase II transcription. Genes Dev 16: 673-675.
144. Tse C, Sera T, Wolffe AP, Hansen JC. (1998). Disruption of higher-order folding by core histone acetylation dramatically enhances transcription of nucleosomal arrays by RNA polymerase III. Mol Cell Biol 18: 4629-4638.
145. Turner N, Tutt A, Ashworth A. (2005). Targeting the DNA repair defect of BRCA tumours. Curr Opin Pharmacol 5: 388-393.
146. Ura K, Araki M, Saeki H, Masutani C, Ito T, Iwai S et al. (2001). ATP-dependent chromatin remodeling facilitates nucleotide excision repair of UV-induced DNA lesions in synthetic dinucleosomes. EMBO J 20: 2004-2014.
147. Verdone L, Caserta M, Di Mauro E. (2005). Role of histone acetylation in the control of gene expression. Biochem Cell Biol 83: 344-353.
148. Vetting MW, S de Carvalho LP, Yu M, Hegde SS, Magnet S, Roderick SL et al. (2005). Structure and functions of the GNAT superfamily of acetyltransferases. Arch Biochem Biophys 433: 212-226.
149. Vlachonasios KE, Thomashow MF, Triezenberg SJ. (2003). Disruption mutations of ADA2b and GCN5 transcriptional adaptor genes dramatically affect Arabidopsis growth, development, and gene expression. Plant Cell 15: 626-638.
150. Vogelauer M, Wu J, Suka N, Grunstein M. (2000). Global histone acetylation and deacetylation in yeast. Nature 408: 495-498.
151. Wang L, Grossman SR, Kieff E. (2000). Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci USA 97: 430-435.
152. Waterborg JH. (2000). Steady-state levels of histone acetylation in Saccharomyces cerevisiae. J Biol Chem 275: 13007-13011.
153. Wieczorek E, Brand M, Jacq X, Tora L. (1998). Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II. Nature 393: 187-191.
154. Winston F, Sudarsanam P. (1998). The SAGA of Spt proteins and transcriptional analysis in yeast: past, present, and future. Cold Spring Harb Symp Quant Biol 63: 553-561.
155. Wolffe AP, Hansen JC. (2001). Nuclear visions: functional flexibility from structural instability. Cell 104: 631-634.
156. Wu PY, Ruhlmann C, Winston F, Schultz P. (2004). Molecular architecture of the S. cerevisiae SAGA complex. Mol Cell 15: 199-208.
157. Xu W, Edmondson DG, Evrard YA, Wakamiya M, Behringer RR, Roth SY. (2000). Loss of Gcn5l2 leads to increased apoptosis and mesodermal defects during mouse development. Nat Genet 26: 229-232.
158. Xu W, Edmondson DG, Roth SY. (1998). Mammalian GCN5 and P/CAF acetyltransferases have homologous aminoterminal domains important for recognition of nucleosomal substrates. Mol Cell Biol 18: 5659-5669.
159. Yamauchi T, Yamauchi J, Kuwata T, Tamura T, Yamashita T, Bae N et al. (2000). Distinct but overlapping roles of histone acetylase PCAF and of the closely related PCAF-B/GCN5 in mouse embryogenesis. Proc Natl Acad Sci USA 97: 11303-11306.
160. Yanagisawa J, Kitagawa H, Yanagida M, Wada O, Ogawa S, Nakagomi M et al. (2002). Nuclear receptor function requires a TFTC-type histone acetyl transferase complex. Mol Cell 9: 553-562.
161. Yang XJ. (2004a). Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26: 1076-1087.
162. Yang XJ. (2004b). The diverse superfamily of lysine acetyltransferases and their roles in leukemia and other diseases. Nucleic Acids Res 32: 959-976.
163. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y. (1996). A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 382: 319-324.
164. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D et al. (1998). Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93: 361-372.
165. Zeng L, Zhou MM. (2002). Bromodomain: an acetyl-lysine binding domain. FEBS Lett 513: 124-128.
166. Zhu B, Zheng Y, Pham AD, Mandal SS, Erdjument-Bromage H, Tempst P et al. (2005). Monoubiquitination of human histone H2B: the factors involved and their roles in HOX gene regulation. Mol Cell 20: 601-611.